Skip to content
Navigating a New Political Landscape: View real-time updates about the impact of and Northeastern's response to recent political changes.
Apply
Stories

mRNA HIV vaccine achieves 97 percent efficacy in George Washington School of Medicine and Health Sciences human trials

People in this story

George Washington Hatchet, January 2023

The George Washington School of Medicine and Health Sciences achieved a 97 percent success rate after conducting the first-ever human trials of the mRNA HIV vaccine over the past year, according to a release the school issued last month.

Researchers created a molecule inside the vaccine that elicits a response from bnAb precursor B cells, which eventually turn into cells that produce bnAbs – neutralizing antibodies that target the HIV virus, according to the study’s release. David Diemert, the clinical director of the GW Vaccine Research Unit, said in the release that the trials produced an efficacy rate that is more than 66 percent higher than any other HIV vaccine that has been tested on humans.

Continue reading at The George Washington Hatchet.

More Stories

A pile of pennies.

Trump says he has directed US Treasury to stop minting new pennies, citing rising cost

02.07.2025
The Sarandí river in Argentina dyed red from pollutant.

Stream Near Buenos Aires Turns Red, ‘Like a River Covered in Blood’

02.07.2025
Trump signing executive orders enacting Project 2025 plans.

Donald Trump shunned Project 2025 as a candidate, but is adopting its ideas in office

02.07.25
All Stories